| > |
The
development of an innovative
drug is a complex process. It
begins with the identification
of lead compounds, the screening
of active substances in pre-clinical
and clinical studies and leads
to the approval of novel drugs.
The average duration of this
process is 10 to 15 years and
requires profound knowledge,
technologies and methods.
The institutes and medical centers
of the University of Frankfurt/
Main can cover almost any aspect
of this value chain. This wealth
of knowledge is combined in
ZAFES and results in the efficient
and competent handling of scientific
questions, a development which
benefits the university, industry
and biotechnology.
|
